The study analysed antibodies in the blood of 250 healthy people who received either one or two doses of the Pfizer-BioNTech COVID-19 vaccine, up to three months after their first dose.
https://ift.tt/eA8V8J The study analysed antibodies in the blood of 250 healthy people who received either one or two doses of the Pfizer-BioNTech COVID-19 vaccine, up to three months after their first dose. from Zee News :India National https://ift.tt/3uUzef1
No comments:
Post a Comment